Concepedia

Thom M. Molenaar

TM

Statistics

Publications

4

Citations

122

H-Index

4

Active since

2016

Affiliations

The Netherlands Cancer Institute(Current)

Oncode Institute

Utrecht University

Amsterdam University Medical Centers

Thom M. Molenaar is an author at The Netherlands Cancer Institute specializing in medicine, epigenomics, and gene expression.

ORCID

Top concepts

Publications per year

2016–2023

4

Publications

4

Conserved crosstalk between histone deacetylation and H3K79 methylation generates DOT1L‐dose dependency in HDAC1‐deficient thymic lymphoma

Hanneke Vlaming, Chelsea McLean, Tessy Korthout et al. · The EMBO Journal · 2019 · 41 citations · Full text

Dot1 promotes H2B ubiquitination by a methyltransferase-independent mechanism

Tibor van Welsem, Tessy Korthout, Reggy Ekkebus et al. · Nucleic Acids Research · 2018 · 35 citations · Full text

, , +17

Direct screening for chromatin status on DNA barcodes in yeast delineates the regulome of H3K79 methylation by Dot1

Hanneke Vlaming, Thom M. Molenaar, Tibor van Welsem et al. · eLife · 2016 · 34 citations · Full text

, , +24

CRISPR screens in sister chromatid cohesion defective cells reveal PAXIP1-PAGR1 as regulator of chromatin association of cohesin

Janne J. M. van Schie, Klaas de Lint, Thom M. Molenaar et al. · Nucleic Acids Research · 2023 · 12 citations · Full text

1–4 of 4